Research Interests
Clinical Research Innovation
Selected Grants
Duke University Maternal-Fetal Medicine Units (MFMU) Network Clinical Center
ResearchCollaborating Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2030Direct-to-family pharmacokinetics intervention for hydroxychloroquine non-adherence in adolescents with systemic lupus erythematosus
ResearchCo-Mentor · Awarded by National Institutes of Health · 2024 - 2029Mentoring in Pediatric Cardiovascular Pharmacology and Early Phase Trials
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028CPCCRN
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2026Duke University Maternal-Fetal Medicine Units (MFMU) Network Clinical Center
ResearchCollaborating Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2023 - 2030Direct-to-family pharmacokinetics intervention for hydroxychloroquine non-adherence in adolescents with systemic lupus erythematosus
ResearchCo-Mentor · Awarded by National Institutes of Health · 2024 - 2029Mentoring in Pediatric Cardiovascular Pharmacology and Early Phase Trials
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028CPCCRN
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2026Personalized Immunomodulation in Pediatric Sepsis-Induced MODS (PRECISE) (CPCCRN)
ResearchPrincipal Investigator · Awarded by University of Utah · 2021 - 2026Deep learning artificial intelligence detection of pediatric heart transplant rejection
ResearchMentor · Awarded by Thrasher Research Fund · 2024 - 2026UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2016 - 2026Pediatric Trials Network_ Task Order 1_ Core Function Activities
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2018 - 2026Duke-UNC Collaborative Pediatric Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2021 - 2026Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2026PTN 2.0 TO #10: Positron-C
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2025Real World Data to Support Pediatric Drug Labeling
ResearchPrincipal Investigator · Awarded by Burroughs Wellcome Fund · 2019 - 2025Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2025Spoonfulone
ResearchPrincipal Investigator · Awarded by Before Brands, Inc. · 2020 - 2024A Phase 1 Study of AAV8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
Clinical TrialPrincipal Investigator · Awarded by Actus Therapeutics · 2018 - 2024You and Me Healthy: Testing Protocol
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2024Duke Summer Training in Academic Research (Duke's STAR)
ResearchMentor · Awarded by National Institutes of Health · 2018 - 2024Evaluating Sertraline Exposure in Breastmilk using Novel Collection Methods
ResearchPrincipal Investigator · Awarded by The Trustees of Indiana University · 2023 - 2024Optimizing caffeine exposure to reduce post-cardiopulmonary bypass acute kidney injury in neonates
ResearchCo-Mentor · Awarded by Thrasher Research Fund · 2022 - 2023Optimizing Hydroxychloroquine to Reduce Disease Activity in Pediatric Lupus
ResearchCo-Mentor · Awarded by Thrasher Research Fund · 2021 - 2023Global Pediatric Clinical Trials Network
ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2017 - 2023PTN2- TO# BPCA Pharmacology Studies
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2018 - 2023PTN 2.0 TO1 Core Function Activities - Option 4
ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2022 - 2023Oxycontin Peds Study (EPM 7254)
ResearchPrincipal Investigator · Awarded by Purdue Pharma · 2021 - 2022Perioperative Tissue Penetration of Antimicrobials in Infants
ResearchPrincipal Investigator · Awarded by Thrasher Research Fund · 2020 - 2022Pediatric Critical Care Research Landscape - A National Expert Conference
ConferencePrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2022PTN 2.0- TO 3 - Option 3 - BPCA Concept Development and Clinical Trial Readiness Support
ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2021 - 2022PTN 2.0 TO 1 Core Function Activities_Option 3
ResearchCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2021 - 2022R21 ICT Tools for Rare Diseases
ResearchPrincipal Investigator · Awarded by Research Triangle Institute International · 2019 - 2021PTN 2.0- TO 3 - Option 2 - BPCA Concept Development and Clinical Trial Readiness Support
ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2020 - 2021Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2021UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021PTN 2.0 TO 1 Core Function Activities_Option 2
Clinical TrialCo Investigator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2020 - 2021PMR 292932: A Nationally Representative Drug Utilization Study of OxyContin in Children Aged 17 Years and Younger
Clinical TrialPrincipal Investigator · Awarded by Purdue Pharma · 2018 - 2021Pharmacokinetics, Pharmacodynamics, and Safety of Methylprednisolone in Neonates on Cardiopulmonary Bypass
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2020PTN2- TO# 3 Concept Development and Clinical Trial Readiness Support Option Period 1
ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2019 - 2020A Phase I Study of the Safety of AAV2/8 LSPhGAA in Late-onset Pompe Disease
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2017 - 2020Pediatric Trials Network_ Task Order 1_ Core Function Activities Option Period 1
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2019 - 2020PTN2- TO# BPCA Concept Development and Clinical Trial Readiness Support
ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2018 - 2019UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2017 - 2019Echocardiogram to Diagnose Pulmonary Hypertension in Premature Infants
ResearchCo Investigator · Awarded by University of North Carolina - Chapel Hill · 2015 - 2019SOLI - Solithromycin Pediatric Development Program (Phase 2/3)- Labor & Sub Cost
Clinical TrialStatistical Investigator · Awarded by Cempra Pharmaceuticals, Inc. · 2016 - 2018PTN Task Order 36- PTN Repository: Modification 1
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2018PTN TO #39: PPE
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2018PTN TO #34: Program Management Support - Option 2
Clinical TrialCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2017 - 2018PTN TO#47 (Protocol Development V)
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2017 - 2018Linking Safety Practices to Adverse Events and Outcomes in Hospitalized Infants
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2018PTN TO#36 - PTN Repository
ResearchPrincipal Investigator · Awarded by National Institute for Child Health & Human Develo · 2015 - 2017PTN TO#40 (Protocol Development IV)
ResearchCo Investigator · Awarded by National Institute for Child Health & Human Develo · 2015 - 2016CISA TO2 Prophylactic Antipyretics Revision 1-A
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2014 - 2016CISA TO2 Prophylactic Antipyretics Revision 3-A
ResearchInvestigator · Awarded by Centers for Disease Control and Prevention · 2014 - 2016CISA TO2 Prophylactic Antipyretics
ResearchCo Investigator · Awarded by Centers for Disease Control and Prevention · 2013 - 2016PTN Task Order--Protocol Development III
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2014 - 2015External Relationships
- Cytokinetics, Inc.
- Lightship
- SC Pharma
- Tellus Therapeutics, Inc.
- UCB Pharma
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.